IDL Biotech AB logo

IDL BTA B - IDL Biotech AB Share Price

SEK2.45 0.0  0.0%

Last Trade - 28/12/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £2.23m
Position in Universe th / 1783
Bullish
Bearish
Unlock IDL BTA B Revenue
Momentum
Relative Strength (%)
1m +65.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
26.4 28.5 33.5 32.3 27.4 28.3 43.0 60.0 +1.4%
+153.2 +12.4 -94.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, IDL Biotech AB revenues decreased 16% to SEK13.1M. Net loss applicable to common stockholders increased 73% to SEK5.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Personnel Expenses increase of 16% to SEK9.5M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -SEK0.05 to -SEK0.09.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IDL BTA B Revenue Unlock IDL BTA B Revenue

Net Income

IDL BTA B Net Income Unlock IDL BTA B Revenue

Normalised EPS

IDL BTA B Normalised EPS Unlock IDL BTA B Revenue

PE Ratio Range

IDL BTA B PE Ratio Range Unlock IDL BTA B Revenue

Dividend Yield Range

IDL BTA B Dividend Yield Range Unlock IDL BTA B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IDL BTA B EPS Forecasts Unlock IDL BTA B Revenue
Profile Summary

IDL Biotech AB is a Sweden-based company that develops, manufactures and markets in vitro diagnostic (IVD) products for the healthcare sector. The Company’s products are divided into two main areas, namely Oncology and Bacteriology. Oncology includes in vitro tumor markers for various for a number of types of cancer, such as breast, lung, prostate, bladder and ovarian cancers. The markers indicate ongoing tumor cell activity, giving measurements on changes in tumor behavior, and provide early signals about the course of the disease. Oncology comprises such products as TPS, TPAcyk, UBC and MonoTotal. Bacteriology offers TUBEX TF, an in vitro diagnostic test for detection of typhoid fever (a Salmonella infection). As of December 31, 2011, the Company had one wholly owned subsidiary, namely IDL Bioscience AB.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since June 26, 2000
No. of Shareholders: n/a
No. of Employees: 18
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange AktieTorget Stock Exchange (Dual Listing)
Shares in Issue 102,685,122
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IDL BTA B Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IDL BTA B
Upcoming Events for IDL BTA B
Frequently Asked Questions for IDL Biotech AB
What is the IDL Biotech AB share price?

As of 28/12/18, shares in IDL Biotech AB are trading at SEK2.45, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the IDL Biotech AB share price performed this year?

Shares in IDL Biotech AB are currently trading at SEK2.45 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the IDL Biotech AB price has moved by % over the past year.

What are the analyst and broker recommendations for IDL Biotech AB?

There are no analysts currently covering IDL Biotech AB.

When will IDL Biotech AB next release its financial results?

IDL Biotech AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the IDL Biotech AB dividend yield?

IDL Biotech AB does not currently pay a dividend.

Does IDL Biotech AB pay a dividend?

IDL Biotech AB does not currently pay a dividend.

When does IDL Biotech AB next pay dividends?

IDL Biotech AB does not currently pay a dividend.

How do I buy IDL Biotech AB shares?

To buy shares in IDL Biotech AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of IDL Biotech AB?

Shares in IDL Biotech AB are currently trading at SEK2.45, giving the company a market capitalisation of £n/a.

Where are IDL Biotech AB shares listed? Where are IDL Biotech AB shares listed?

Here are the trading details for IDL Biotech AB:

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: IDL BTA B
What kind of share is IDL Biotech AB?

We were not able to load our ranking data for IDL Biotech AB

Is there a IDL Biotech AB share price forecast 2020?

We were not able to load any forecast data for IDL Biotech AB.

How can I tell whether the IDL Biotech AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like IDL Biotech AB. Over the past six months, the relative strength of its shares against the market has been %. At the current price of SEK2.45, shares in IDL Biotech AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the IDL Biotech AB PE Ratio?

We were not able to find PE ratio data for IDL Biotech AB.

Who are the key directors of IDL Biotech AB?

IDL Biotech AB's management team is headed by:

Jerker Swanstein - CHM
Lars Skoglund - VPR
Ola Eklund - OTH
Charlotte Berg - CEO
Robert Nilsson - OTH
Martyn Eales - SVP
Marie Torstensson - DMK
Per-Anders Abrahamsson - DRC
Carsten Olsson - DRC
Nick Thliveris - OTH
Anne-Christine Nilsson - VRD
Nick Bright - OTH
Eva Saers - DRC
Malin Ruijsenaars - DRC
Who are the major shareholders of IDL Biotech AB?

Here are the top five shareholders of IDL Biotech AB based on the size of their shareholding:

Similar to IDL BTA B
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.